Levo-transposition of the great arteries lab tests

Revision as of 12:54, 13 August 2011 by Priyamvada Singh (talk | contribs)
Jump to navigation Jump to search

Levo-transposition of the great arteries Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Levo-transposition of the great arteries from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

Cardiac catheterization

ACC/AHA Guidelines for Clinical Evaluation and Follow Up

Treatment

ACC/AHA recommendations for surgical intervention
Post-operative care
Prevention
ACC/AHA recommendations for reproduction

Case Studies

Case #1

Levo-transposition of the great arteries lab tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Levo-transposition of the great arteries lab tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Levo-transposition of the great arteries lab tests

CDC on Levo-transposition of the great arteries lab tests

Levo-transposition of the great arteries lab tests in the news

Blogs on Levo-transposition of the great arteries lab tests

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Levo-transposition of the great arteries lab tests

Transposition of the great vessels Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Dextro-transposition of the great arteries
L-transposition of the great arteries

Pathophysiology

Causes

Differentiating Transposition of the great vessels from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Palliative care
Corrective surgery
Post-operative care
Follow up

Prevention

Reproduction

Case Studies

Case #1

Levo-transposition of the great arteries lab tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Levo-transposition of the great arteries lab tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Levo-transposition of the great arteries lab tests

CDC on Levo-transposition of the great arteries lab tests

Levo-transposition of the great arteries lab tests in the news

Blogs on Levo-transposition of the great arteries lab tests

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Levo-transposition of the great arteries lab tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]

Overview

The(ACC/AHA) recommendations for evaluation and follow-up of patients with Congenitally corrected transposition of the great arteries (CCTGA) [1](DONOT EDIT)

Class I

1. All patients with CCTGA should have a regular follow-up with a cardiologist who has expertise in adult congenital heart disease (ACHD). (Level of Evidence: C)

2. Echocardiography-Doppler study and/or magnetic resonance imaging (MRI) should be performed yearly or at least every other year by staff trained in imaging complex congenital heart disease (CHD). (Level of Evidence: C) 3. The following diagnostic evaluations are recommended for patients with CCTGA:

1. Electrocardiogram (ECG). (Level of Evidence: C)
2. Chest x-ray. (Level of Evidence: C)
3. Echocardiography-Doppler study. (Level of Evidence: C)
4. MRI. (Level of Evidence: C)
5. Exercise testing. (Level of Evidence: C)

Interventional Therapy

Recommendations for Catheter Interventions

Class IIa

1. For patients with unrepaired CCTGA, cardiac catheterization can be effective to assess the following:

1. Hemodynamic status in the setting of arrhythmia. (Level of Evidence: C)
2. Unexplained systemic ventricle (SV) dysfunction, to define the degree of systemic AV valve regurgitation, degree of intracardiac shunting, and coronary artery anatomy. (Level of Evidence: C)
3. Unexplained volume retention or cyanosis, especially when noninvasive assessment of pulmonary outflow obstruction is limited. (Level of Evidence: C)

References

  1. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.